Eva Coll de la Rubia

Eva Coll de la Rubia currently serves as a Translational Scientist at ProQR Therapeutics, focusing on building translational science capabilities for drug discovery and early programs. Previously, at MiMARK, Eva functioned as a Project Lead and Scientist, leading the development of an IVD test for endometrial cancer and applying extensive scientific knowledge to ensure its safety and effectiveness. Eva Coll de la Rubia's academic background includes a PhD in Biochemistry, Molecular Biology, and Biomedicine from Universitat Autònoma de Barcelona, complemented by master's degrees in Bioinformatics and Biostatistics, and Translational Biomedical Research, as well as a Bachelor’s Degree in Biotechnology. With research experience at institutes such as Vall d’Hebron Institute of Research and Luxembourg Institute of Health, Eva has a strong foundation in translational research and a focus on biomarkers for gynecological cancers.